Pegylated liposomal doxorubicin treatment in patients with refractory or relapsed central nervous system (CNS) lymphoma.

被引：0
|
作者：
Calvisi, A [1 ]
Palmas, AD [1 ]
Lai, P [1 ]
Bianchi, A [1 ]
Murgia, A [1 ]
Gaviano, E [1 ]
Noli, AL [1 ]
Curreli, L [1 ]
Gabbas, A [1 ]
机构：
[1] San Francisco Hosp, Hematol & BMT Ctr, Nuoro, Italy
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4750
引用
收藏
页码：302B / 303B
页数：2
相关论文
共 50 条
  • [1] Liposomal cytarabine in the treatment of primary or relapsed malignant lymphoma with central nervous system (CNS) involvement
    Thorsgaard, M.
    D'Amore, F.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 225 - 225
  • [2] Intraventricular treatment of relapsed and refractory central nervous system (CNS) lymphoma with rituximab.
    Schulz, H
    Pels, H
    Hom, E
    Thall, A
    Engert, A
    [J]. BLOOD, 2001, 98 (11) : 249B - 249B
  • [3] A Phase 1 Trial of Vorinostat and Pegylated Liposomal Doxorubicin In Relapsed or Refractory Lymphoma
    Lansigan, Frederick
    Seropian, Stuart
    Cooper, Dennis L.
    Potter, Von
    Sowers, Noelle
    Foss, Francine M.
    [J]. BLOOD, 2010, 116 (21) : 1161 - 1162
  • [4] Nivolumab and Ibrutinib for Treatment of Patients with Refractory or Relapsed Central Nervous System Lymphoma
    Westin, Jason
    Nair, Ranjit
    Fayad, Luis
    Iyer, Swami P.
    Malpica, Luis
    Neelapu, Sattva S.
    Samaniego, Felipe
    Steiner, Raphael Eric
    Strati, Paolo
    Mathew, Shivon
    Griffith, Donna
    Nastoupil, Loretta J.
    Montinez, Wirt
    Rodriguez, Maria Alma
    Hagemeister, Frederick
    Feng, Lei
    Vega, Francisco
    Flowers, Christopher R.
    Ahmed, Sairah
    [J]. BLOOD, 2023, 142
  • [5] Pegylated liposomal doxorubicin (Doxil®) is active in the treatment of relapsed/refractory lymphomas.
    Tulpule, A
    Justice, G
    Espina, BM
    Harvey-Buchanan, L
    Barut, L
    Khan, A
    Levine, AM
    [J]. BLOOD, 1998, 92 (10) : 241B - 241B
  • [6] Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma
    Raizer, Jeffrey J.
    Rademaker, Alfred
    Evens, Andrew M.
    Rice, Laurie
    Schwartz, Margaret
    Chandler, James P.
    Getch, Christopher C.
    Tellez, Claudia
    Grimm, Sean A.
    [J]. CANCER, 2012, 118 (15) : 3743 - 3748
  • [7] Pegylated liposomal doxorubicin and bortezomib in relapsed/refractory multiple myeloma
    不详
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (07): : 453 - 455
  • [8] Salvage therapy with gemcitabine, vinorelbine, and pegylated liposomal doxorubicin for relapsed or refractory pediatric Hodgkin lymphoma. Results of a retrospective series of four children
    Jaffray, Marie
    Buchbinder, Nimrod
    Lutun, Anne
    Schneider, Pascale
    Piquenot, Jean-Michel
    Vannier, Jean-Pierre
    [J]. ANNALS OF HEMATOLOGY, 2015, 94 (08) : 1401 - 1406
  • [9] Salvage therapy with gemcitabine, vinorelbine, and pegylated liposomal doxorubicin for relapsed or refractory pediatric Hodgkin lymphoma. Results of a retrospective series of four children
    Marie Jaffray
    Nimrod Buchbinder
    Anne Lutun
    Pascale Schneider
    Jean-Michel Piquenot
    Jean-Pierre Vannier
    [J]. Annals of Hematology, 2015, 94 (8) : 1401 - 1406
  • [10] Pegylated Liposomal Doxorubicin A Review of its Use in the Treatment of Relapsed or Refractory Multiple Myeloma
    Plosker, Greg L.
    [J]. DRUGS, 2008, 68 (17) : 2535 - 2551
12345